Appendix A, Table 2. COVID-19 Treatment Guidelines Panel Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics
Last Updated: August 8, 2022
Reporting Period: April 1, 2021, to March 31, 2022
Panel Member | Financial Disclosure | |
---|---|---|
Company | Relationship | |
Judith Aberg, MD | Atea Pharmaceuticals | Research support |
Emergent BioSolutions | Research support | |
Gilead Sciences | Research support | |
GSK | Advisory board, research support | |
GSK/ViiV Healthcare | Advisory board, research support | |
Janssen | Research support | |
Merck & Co. | Advisory board, research support | |
Pfizer | Research support | |
Regeneron | Research support | |
Adaora Adimora, MD, MPH | Gilead Sciences | Research support, consultant |
Merck & Co. | Advisory board, research support | |
Jason Baker, MD, MS | Humanigen | Research support |
Lisa Baumann Kreuziger, MD, MS | 3M | Stockholder, spouse is an employee |
Versiti | Employee | |
Roger Bedimo, MD, MS | Gilead Sciences | Advisory board |
GSK/ViiV Healthcare | Advisory board | |
Janssen | Advisory board | |
Merck & Co. | Advisory board, research support | |
Pamela S. Belperio, PharmD | None | N/A |
Anoopindar Bhalla, MD | None | N/A |
John T. Brooks, MD | None | N/A |
Timothy Burgess, MD | AstraZeneca | Research support |
Danielle M. Campbell, MPH | Gilead Sciences | Advisory board |
GSK/ViiV Healthcare | Attendee at the community stakeholder meeting | |
Stephen V. Cantrill, MD | None | N/A |
Kathleen Chiotos, MD, MSCE | None | N/A |
Craig Coopersmith, MD | None | N/A |
Page Crew, PharmD, MPH | None | N/A |
Eric Daar, MD | Gilead Sciences | Consultant, research support |
GSK/ViiV Healthcare | Consultant, research support | |
Merck & Co. | Consultant, research support | |
Demetre Daskalakis, MD, MPH | None | N/A |
Richard T. Davey, Jr., MD | None | N/A |
Laurie K. Doepel, BA | None | N/A |
Amy L. Dzierba, PharmD | None | N/A |
Derek Eisnor, MD | None | N/A |
Gregory Eschenauer, PharmD | None | N/A |
Laura Evans, MD, MSc | None | N/A |
Joseph Francis, MD, MPH | None | N/A |
John J. Gallagher, DNP, RN | None | N/A |
Rajesh Gandhi, MD | None | N/A |
David V. Glidden, PhD | None | N/A |
Steve Grapentine, PharmD | None | N/A |
Birgit Grund, PhD | None | N/A |
Roy M. Gulick, MD, MPH | None | N/A |
Alison Han, MD | None | N/A |
Erica J. Hardy, MD, MMSc | None | N/A |
Carly Harrison | AstraZeneca | Advisory board, consultant |
Aurinia Pharmaceuticals | Advisory board, stockholder | |
UCB | Advisory board, consultant | |
Lauren Henderson, MD, MMSc | Adaptive Biotechnologies | Consultant |
Bristol Myers Squibb | Research support | |
Pfizer | External panel for grant reviews | |
Sobi | Advisory board, consultant, research support | |
Skygenic | Consultant, spouse is an employee | |
Elizabeth S. Higgs, MD, DTM&H, MIA | None | N/A |
Carl Hinkson, MSRC | None | N/A |
Brenna L. Hughes, MD, MSc | None | N/A |
Steven Johnson, MD | GSK/ViiV Healthcare | Advisory board |
Marla J. Keller, MD | None | N/A |
Arthur Kim, MD | Kintor Pharmaceutical | Data and safety monitoring board chair/member |
Safia Kuriakose, PharmD | None | N/A |
H. Clifford Lane, MD | None | N/A |
Jeffrey L. Lennox, MD | None | N/A |
Andrea M. Lerner, MD, MS | None | N/A |
Mitchell M. Levy, MD | None | N/A |
Jonathan Li, MD, MMSc | None | N/A |
Gregory Martin, MD, MSc | Genentech | Data and safety monitoring board chair/member |
Grifols | Research grants review panel | |
Henry Masur, MD | None | N/A |
Susanna Naggie, MD, MHS | AbbVie | Research support, funding via NIH-supported trial |
Bristol Myers Squibb | Event adjudication committee | |
FHI 360 | Event adjudication committee | |
Gilead Sciences | Research support | |
Pardes Biosciences | Consultant | |
Silverback Therapeutics | Consultant | |
Vir Biotechnology | Advisory board, stockholder, stock options | |
Martha C. Nason, PhD | None | N/A |
Alice K. Pau, PharmD | None | N/A |
Andrew T. Pavia, MD | GlaxoSmithKline | Advisory board |
Michael Proschan, PhD | None | N/A |
Renee Ridzon, MD | None | N/A |
Grant Schulert, MD, PhD | Novartis | Honoraria |
Nitin Seam, MD | None | N/A |
Virginia Sheikh, MD, MHS | None | N/A |
Steven Q. Simpson, MD | None | N/A |
Kanal Singh, MD, MPH | None | N/A |
Renee Stapleton, MD, PhD | Altimmune | Data and safety monitoring board chair |
CSL Behring | Consultant | |
Susan Swindells, MBBS | GSK/ViiV Healthcare | Research support |
Pablo Tebas, MD | Gilead Sciences | Consultant |
GSK/ViiV Healthcare | Consultant | |
Merck & Co. | Consultant | |
Phyllis Tien, MD, MSc | Eli Lilly | Research support |
Gilead Sciences | Research support | |
Merck & Co. | Research support | |
Timothy M. Uyeki, MD, MPH | None | N/A |
Alpana A. Waghmare, MD | AlloVir | Research support |
Ansun BioPharma | Research support | |
Deverra Therapeutics | Data and safety monitoring board member | |
KYORIN Pharmaceutical Co. | Advisory board | |
Pfizer | Research support | |
Vir Biotechnology | Research support | |
Jinoos Yazdany, MD, MPH | AstraZeneca | Consulting and research support related to lupus |
Aurinia | Consulting related to lupus drug | |
Bristol Myers Squibb | Research support | |
Pfizer | Consultant, lecture presenter |